These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6979309)

  • 21. Kinetic studies of mefloquine and of one of its metabolites, Ro 21-5104, in the dog and in man.
    Schwartz DE; Weber W; Richard-Lenoble D; Gentilini M
    Acta Trop; 1980 Sep; 37(3):238-42. PubMed ID: 6106360
    [No Abstract]   [Full Text] [Related]  

  • 22. The susceptibility of the malarial parasite Plasmodium falciparum to quinoline-containing drugs is correlated to the lipid composition of the infected erythrocyte membranes.
    Shalmiev G; Ginsburg H
    Biochem Pharmacol; 1993 Aug; 46(3):365-74. PubMed ID: 8347162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heme binding contributes to antimalarial activity of bis-quaternary ammoniums.
    Biagini GA; Richier E; Bray PG; Calas M; Vial H; Ward SA
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2584-9. PubMed ID: 12878523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of a new antimalarial, mefloquine.
    Desjardins RE; Pamplin CL; von Bredow J; Barry KG; Canfield CJ
    Clin Pharmacol Ther; 1979 Sep; 26(3):372-9. PubMed ID: 466930
    [No Abstract]   [Full Text] [Related]  

  • 25. Modification of host cell membrane lipid composition by the intra-erythrocytic human malaria parasite Plasmodium falciparum.
    Hsiao LL; Howard RJ; Aikawa M; Taraschi TF
    Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):121-32. PubMed ID: 2001227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural organization and dynamics of phospholipids in red cell membranes.
    van Deenen LL
    Prog Clin Biol Res; 1979; 30():451-6. PubMed ID: 531035
    [No Abstract]   [Full Text] [Related]  

  • 27. Diverse membrane-active agents modify the hemolytic response to ferriprotoporphyrin IX.
    Dutta P; Fitch CD
    J Pharmacol Exp Ther; 1983 Jun; 225(3):729-34. PubMed ID: 6602875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation of erythrocyte membrane phospholipids in patients with myotonic and Duchenne muscular dystrophy.
    Moore RB; Appel SH
    Exp Neurol; 1980 Nov; 70(2):380-91. PubMed ID: 7428902
    [No Abstract]   [Full Text] [Related]  

  • 29. Photoaffinity labeling of mefloquine-binding proteins in human serum, uninfected erythrocytes and Plasmodium falciparum-infected erythrocytes.
    Desneves J; Thorn G; Berman A; Galatis D; La Greca N; Sinding J; Foley M; Deady LW; Cowman AF; Tilley L
    Mol Biochem Parasitol; 1996 Nov; 82(2):181-94. PubMed ID: 8946384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment of Plasmodium falciparum-infected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase.
    Famin O; Ginsburg H
    Parasite; 2003 Mar; 10(1):39-50. PubMed ID: 12669348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of the organization of erythrocyte membrane phospholipids by cytoplasmic ATP. The susceptibility of isoionic human erythrocytes ghosts to attack by detergents and phospholipase C.
    Shukla SD; Billah MM; Coleman R; Finean JB; Michell RH
    Biochim Biophys Acta; 1978 May; 509(1):48-57. PubMed ID: 647008
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of phospholipase A2 treatment of human erythrocyte membranes on the rates of spectrin-actin dissociation.
    Gottlieb MH
    Biochim Biophys Acta; 1982 Mar; 686(1):133-6. PubMed ID: 7066319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinoline antimalarials: mechanisms of action and resistance.
    Foley M; Tilley L
    Int J Parasitol; 1997 Feb; 27(2):231-40. PubMed ID: 9088993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inhibitory effect of a drug combination on the development of mefloquine resistance in Plasmodium berghei.
    Merkli B; Richle R; Peters W
    Ann Trop Med Parasitol; 1980 Feb; 74(1):1-9. PubMed ID: 6990883
    [No Abstract]   [Full Text] [Related]  

  • 35. Hydrolytic activities of human pancreatic phospholipase A2 and endotoxin-stimulated endogenous phospholipase A2 toward membrane phospholipids of erythrocytes.
    Nishijima J; Okamoto M; Yamano T; Nakaguchi K; Ogawa M
    J Surg Res; 1985 Mar; 38(3):237-45. PubMed ID: 3884899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exposure of human red blood cell membrane phospholipids to ringhals (Hemachatus haemachates) venom phospholipase A. A re-evaluation of substrate specificity reversal.
    Condrea E
    Toxicon; 1979; 17(1):27-8. PubMed ID: 419535
    [No Abstract]   [Full Text] [Related]  

  • 37. Parasite-regulated membrane transport processes and metabolic control in malaria-infected erythrocytes.
    Elford BC; Cowan GM; Ferguson DJ
    Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):361-74. PubMed ID: 7772015
    [No Abstract]   [Full Text] [Related]  

  • 38. Stimulation of Suicidal Erythrocyte Death by the Antimalarial Drug Mefloquine.
    Bissinger R; Barking S; Alzoubi K; Liu G; Liu G; Lang F
    Cell Physiol Biochem; 2015; 36(4):1395-405. PubMed ID: 26159705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimalarial activity of mefloquine and chloroquine against blood induced Plasmodium knowlesi infection in rhesus monkeys.
    Singh PP; Dutta GP
    Indian J Med Res; 1981 Jan; 73 Suppl():23-8. PubMed ID: 6974694
    [No Abstract]   [Full Text] [Related]  

  • 40. Direct interaction of mepacrine with erythrocyte and platelet membrane phospholipid.
    Dise CA; Burch JW; Goodman DB
    J Biol Chem; 1982 May; 257(9):4701-4. PubMed ID: 6802839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.